Drug Shortage Report for CEFTRIAXONE FOR INJECTION
| Report ID | 57919 |
| Drug Identification Number | 02409968 |
| Brand name | CEFTRIAXONE FOR INJECTION |
| Common or Proper name | CefTRIAXone for Injection |
| Company Name | FRESENIUS KABI CANADA LTD |
| Market Status | MARKETED |
| Active Ingredient(s) | CEFTRIAXONE |
| Strength(s) | 100G |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | INTRAVENOUS |
| Packaging size | 100g SmartPak |
| ATC code | J01DD |
| ATC description | OTHER BETA-LACTAM ANTIBACTERIALS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2018-07-13 |
| Actual start date | |
| Estimated end date | Unknown |
| Actual end date | 2018-11-14 |
| Shortage status | Resolved |
| Updated date | 2020-01-16 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2020-01-16 | French | Compare |
| v5 | 2020-01-16 | English | Compare |
| v4 | 2018-11-02 | French | Compare |
| v3 | 2018-11-02 | English | Compare |
| v2 | 2018-08-10 | French | Compare |
| v1 | 2018-08-10 | English | Compare |
Showing 1 to 6 of 6